Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Follicular

Explore clinical trials studying Lymphoma, Follicular. Study availability and eligibility vary by location and protocol.

1,362 public trials 202 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Follicular trial results

Recruiting

NEO100 and High-Grade Meningioma

NCT05023018

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • University of Southern California Los Angeles, California, United States
  • Sutter Health Research Institute San Francisco, California, United States
  • Saint John Cancer Institute Santa Monica, California, United States
  • Tufts Medical Center Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

NCT07101328

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +23 more
Locations
  • City of Hope Duarte, California, United States
  • University of Colorado Denver - School of Medicine - Anschutz Medical Campus Aurora, Colorado, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Yale University School of Medicine - Yale Cancer Center New Haven, Connecticut, United States
View all 50 locations
View Trial Details
Recruiting

A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma

NCT03460977

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Disease Attributes, +23 more
Locations
  • Banner-University Medical Center Tucson Tucson, Arizona, United States
  • The University of Arizona Cancer Center-North Campus Tucson, Arizona, United States
  • The University of Arizona Cancer Center Tucson, Arizona, United States
  • Arizona Urology Specialists, PLLC Tucson, Arizona, United States
View all 83 locations
View Trial Details
Recruiting

Pharmacokinetics and Safety Study of Pelabresib in Patients With Advanced Malignancies and Hepatic Impairment

NCT07422610

Conditions
Advanced Malignancies and Hepatic Impairment, Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • Novartis Investigative Site Bordeaux, France
  • Novartis Investigative Site Saint-Herblain, France
  • Novartis Investigative Site Candiolo, TO, Italy
  • Novartis Investigative Site Pozuelo de Alarcón, Madrid, Spain
View Trial Details
Recruiting

A Long-term Extension Study of PCI-32765 (Ibrutinib)

NCT01804686

Conditions
Blood Protein Disorders, Bronchial Diseases, Bronchiolitis, +43 more
Locations
  • City of Hope Cancer Center Duarte, California, United States
  • University of California San Diego Medical Center La Jolla, California, United States
  • University of California Los Angeles Los Angeles, California, United States
  • St. Joseph Hospital Center for Cancer Prevention and Treatment Orange, California, United States
View all 175 locations
View Trial Details
Recruiting

Study of Subcutaneous Epcoritamab in Combination With Intravenous Rituximab and Oral Lenalidomide (R2) to Assess Adverse Events and Change in Disease Activity in Adult Participants With Previously Untreated Follicular Lymphoma

NCT06191744

Conditions
Follicular Lymphoma (FL), Hemic and Lymphatic Diseases, Immune System Diseases, +8 more
Locations
  • UCSF Fresno /ID# 264712 Fresno, California, United States
  • Scripps Mercy Hospital /ID# 265393 San Diego, California, United States
  • Sansum Clinic Research /ID# 261596 Santa Barbara, California, United States
  • Rocky Mountain Cancer Centers - Boulder /ID# 261203 Boulder, Colorado, United States
View all 266 locations
View Trial Details

Related conditions